RxDoctor Payments Data

Gerald Wasko, MD

Family Medicine · Youngstown, OHNPI 1265874267

Payments from drug & device makers

$808in general payments, 2019–2025

Across 60 payments — averaging $13.47 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$145
  • GSK$127
  • Novo Nordisk$126
  • Pfizer$72
  • AstraZeneca$65
  • Merck$49
  • plus $224 from 9 others

What the payments were for

  • Food & beverage$808100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
22

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$808 in reported general payments places this provider in the 60th percentile of 3,983 family medicine providers in Ohio.

See all family medicine providers in Ohio

Medicare billing

Part B allowed, 2024
$27,417
Medicare patients
85
Services billed
383

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban81$97,742
JardianceEmpagliflozin56$69,204
OzempicSemaglutide64$65,513
TrulicityDulaglutide47$58,754
Trelegy ElliptaFluticasone/Umeclidin/Vilanter42$39,571
DescovyEmtricitabine/Tenofov Alafenam13$33,262
MounjaroTirzepatide23$31,917
RybelsusSemaglutide13$25,974
TradjentaLinagliptin32$25,208
FarxigaDapagliflozin Propanediol18$22,932
CreonLipase/Protease/Amylase21$19,017
JanuviaSitagliptin Phosphate13$15,680
VyvanseLisdexamfetamine Dimesylate37$14,215
Spiriva HandihalerTiotropium Bromide16$12,865
Anoro ElliptaUmeclidinium Brm/Vilanterol Tr23$12,444

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$72$97,74281 claims
Boehringer IngelheimJardiance, Tradjenta$39$94,41288 claims
Novo NordiskOzempic, Rybelsus$126$91,48877 claims
Lilly USA, LLCTrulicity, Mounjaro$23$90,67270 claims
GSKTrelegy Ellipta, Anoro Ellipta$127$52,01565 claims
AstraZenecaFarxiga$65$22,93218 claims
AbbVieCreon, Synthroid$11$22,26758 claims
MerckJanuvia$49$15,68013 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 60th percentile of 3,983 family medicine providers in Ohio.

Other family medicine in Youngstown

See the full list for Ohio

Where these figures come from

Is this you, or does something look wrong? →